Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mihai Netea and Hans van der Hoeven.
Mihai Netea
Connection Strength
0.601
Hans van der Hoeven
  1. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020 04 27; 9.
    View in: PubMed
    Score: 0.220
  2. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J Infect Dis. 2021 04 23; 223(8):1322-1333.
    View in: PubMed
    Score: 0.059
  3. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes (Lond). 2021 03; 45(3):687-694.
    View in: PubMed
    Score: 0.058
  4. Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study. Crit Care. 2020 12 10; 24(1):688.
    View in: PubMed
    Score: 0.057
  5. Presence of Genetic Variants Among Young Men With Severe COVID-19. JAMA. 2020 08 18; 324(7):663-673.
    View in: PubMed
    Score: 0.056
  6. Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19. JAMA Netw Open. 2020 08 03; 3(8):e2017708.
    View in: PubMed
    Score: 0.056
  7. Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation. EBioMedicine. 2018 Jul; 33:144-156.
    View in: PubMed
    Score: 0.048
  8. Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo. Front Immunol. 2017; 8:1600.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.